2o4z: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2o4z.png|left|200px]] | [[Image:2o4z.png|left|200px]] | ||
{{STRUCTURE_2o4z| PDB=2o4z | SCENE= }} | {{STRUCTURE_2o4z| PDB=2o4z | SCENE= }} | ||
===Crystal structure of the Carbonic Anhydrase II complexed with hydroxysulfamide inhibitor=== | ===Crystal structure of the Carbonic Anhydrase II complexed with hydroxysulfamide inhibitor=== | ||
{{ABSTRACT_PUBMED_17346964}} | {{ABSTRACT_PUBMED_17346964}} | ||
==About this Structure== | ==About this Structure== | ||
[[2o4z]] is a 1 chain structure of [[Carbonic anhydrase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2O4Z OCA]. | |||
==See Also== | |||
*[[Carbonic anhydrase|Carbonic anhydrase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:017346964</ref><references group="xtra"/> | ||
[[Category: Carbonate dehydratase]] | [[Category: Carbonate dehydratase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 32: | Line 23: | ||
[[Category: Winum, J Y.]] | [[Category: Winum, J Y.]] | ||
[[Category: Carbonic anhydrase]] | [[Category: Carbonic anhydrase]] | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Lyase]] | |||
Revision as of 04:17, 26 July 2012
Crystal structure of the Carbonic Anhydrase II complexed with hydroxysulfamide inhibitorCrystal structure of the Carbonic Anhydrase II complexed with hydroxysulfamide inhibitor
Template:ABSTRACT PUBMED 17346964
About this StructureAbout this Structure
2o4z is a 1 chain structure of Carbonic anhydrase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Temperini C, Winum JY, Montero JL, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors. Bioorg Med Chem Lett. 2007 May 15;17(10):2795-801. Epub 2007 Feb 28. PMID:17346964 doi:http://dx.doi.org/10.1016/j.bmcl.2007.02.068